Ivenix develops a next-generation infusion system that integrates advanced information technology with a redesigned pump platform to improve accuracy, efficiency, and safety. The Ivenix Infusion System provides immediate, secure access to patient-specific infusion and pump management information and features an intuitive, smartphone-like user interface. The product combines fundamentally new pump technology with IT capabilities to address large-volume infusion delivery and interoperability with hospital EMRs. Ivenix plans to pursue FDA clearance and will use the financing to expand its team ahead of commercial launch. The company highlights a $6 billion global infusion pump market and frames its system as a response to persistent patient safety issues and lack of innovation. Ivenix is headquartered in Amesbury, Massachusetts; the U.S. FDA has not yet reviewed the Ivenix Infusion System. Ivenix provides an infusion management system for hospitals that combines a new pump delivery system, a smartphone-like user interface and an information technology system that shares infusion data with the patient’s electronic medical record. The product is designed to improve patient safety and workflow efficiency in clinical settings. The company is led by Jesse Ambrosina and is based in Amesbury, MA. Ivenix closed a $42M equity financing to support its operations. The new funding will support the company’s efforts to enter the global infusion market.

Total raised

$92M

Funding rounds

2

Latest round

Equity

Latest activity

Mar 2017